Cite
HARVARD Citation
VanderWalde, A. et al. (n.d.). Activity and safety of ipatasertib (ipat) for AKT activating mutation and/ or PTEN loss/loss of function solid tumors from MyTACTIC. European journal of cancer. pp. S71-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
VanderWalde, A. et al. (n.d.). Activity and safety of ipatasertib (ipat) for AKT activating mutation and/ or PTEN loss/loss of function solid tumors from MyTACTIC. European journal of cancer. pp. S71-. [Online].